10x Genomics (TXG) Payables (2018 - 2025)
Historic Payables for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $12.7 million.
- 10x Genomics' Payables fell 136.34% to $12.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.7 million, marking a year-over-year decrease of 136.34%. This contributed to the annual value of $12.7 million for FY2025, which is 136.34% down from last year.
- As of Q4 2025, 10x Genomics' Payables stood at $12.7 million, which was down 136.34% from $18.1 million recorded in Q3 2025.
- Over the past 5 years, 10x Genomics' Payables peaked at $29.3 million during Q1 2023, and registered a low of $10.1 million during Q1 2025.
- Over the past 5 years, 10x Genomics' median Payables value was $18.5 million (recorded in 2023), while the average stood at $19.0 million.
- Per our database at Business Quant, 10x Genomics' Payables skyrocketed by 26846.46% in 2021 and then crashed by 5019.79% in 2025.
- 10x Genomics' Payables (Quarter) stood at $17.4 million in 2021, then rose by 24.48% to $21.6 million in 2022, then dropped by 27.14% to $15.7 million in 2023, then fell by 17.98% to $12.9 million in 2024, then fell by 1.36% to $12.7 million in 2025.
- Its Payables was $12.7 million in Q4 2025, compared to $18.1 million in Q3 2025 and $15.9 million in Q2 2025.